Retinoblastoma incidence and survival in European children (1978–1997). Report from the Automated Childhood Cancer Information System project


      Based on 2283 cases of retinoblastoma diagnosed in children aged 0–14 years, incidence and survival in Europe during the period 1978–1997 are described. Data were provided to the Automated Childhood Cancer Information System (ACCIS) from 60 paediatric and general cancer registries. During 1988–1997, the cumulative incidence of retinoblastoma in the ACCIS regions was found to be between 44.2 and 67.9 per million births. The highest incidence was seen in the first year of life. The age-standardised (World standard) incidence rate for the age-range 0–14 years was 4.1 per million. Approximately one-third of cases had bilateral tumours. Overall incidence increased over the period 1978–1997 by 1% per year, as derived from a model adjusted for sex, age group and type of registry (general or paediatric). The 5-year survival rate improved from 89% to 95% during the period covered by the study. This improvement was seen in both unilateral and bilateral cases but was significant only for the unilateral tumours. Survival was lower in the East region, although smaller differences were also observed between the other four regions (British Isles, North, South and West). Availability and quality of registration data on retinoblastoma need to be improved for effective evaluation of incidence and survival.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to European Journal of Cancer
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


      1. Parkin DM, Stiller CA, Draper GJ, Bieber CA, Terracini B, Young JL. International incidence of childhood cancer. IARC scientific publications no. 87. Lyon: International Agency for Research on Cancer;1988.

      2. Parkin DM, Kramárová E, Draper GJ, et al. International incidence of childhood cancer, volume 2. IARC scientific publications no. 144. Lyon: International Agency for Research on Cancer; 1998.

        • Sanders B.M.
        • Draper G.J.
        • Kingston J.E.
        Retinoblastoma in Great Britain 1969–80: incidence, treatment, and survival.
        Br J Ophthalmol. 1988; 72: 576-583
        • Lohmann D.R.
        • Gerick M.
        • Brandt B.
        • et al.
        Constitutional RB1-gene mutations in patients with isolated unilateral retinoblastoma.
        Am J Hum Genet. 1997; 61: 282-294
        • Yandell D.W.
        • Campbell T.A.
        • Dayton S.H.
        • et al.
        Oncogenic point mutations in the human retinoblastoma gene: their application to genetic counseling.
        N Eng J Med. 1989; 321: 1689-1695
        • Lohmann D.R.
        • Gallie B.L.
        Retinoblastoma: revisiting the model prototype of inherited cancer.
        Am J Med Genet Part C (Semin Med Genet). 2004; 129: 23-28
        • Kroll M.E.
        • Passmore S.J.
        • Stiller C.A.
        • et al.
        Childhood cancer – UK.
        in: Toms J.R. CancerStats Monograph 2004. Cancer Research UK, London2004: 63-72
      3. Young JL, Smith MA, Roffers SD, Liff JM, Bunin GR. Retinoblastoma. In: Ries LAG , Smith MA, Gurney JG, et al., editors. Cancer incidence and survival among children and adolescents: United States SEER Program 1975–1995. Bethesda, MD: NIH Pub No 99-4649; 1999, p. 73–8.

        • Sant M.
        • Capocaccia R.
        • Badioni V.
        • and the EUROCARE Working Group
        Survival for retinoblastoma in Europe.
        Eur J Cancer. 2001; 37: 730-735
        • Beck M.N.
        • Balmer A.
        • Dessing C.
        • Pica A.
        • Munier F.
        First-line chemotherapy with local treatment can prevent external-beam irradiation and enucleation in low-stage intraocular retinoblastoma.
        J Clin Oncol. 2000; 18: 2881-2887
        • Honavar S.G.
        • Singh A.D.
        • Shields C.L.
        • et al.
        Postenucleation adjuvant therapy in high-risk retinoblastoma.
        Arch Ophthalmol. 2002; 120: 923-931
        • Shields C.L.
        • Honavar S.G.
        • Meadows A.T.
        • et al.
        Chemoreduction plus focal therapy for retinoblastoma: factors predictive of need for treatment with external beam radiotherapy or enucleation.
        Am J Ophthalmol. 2002; 133: 657-664
        • DiCiommo D.
        • Gallie B.L.
        • Bremner R.
        Retinoblastoma: the disease, gene and protein provide critical leads to understand cancer.
        Semin Cancer Biol. 2000; 10: 255-269
        • Abramson D.H.
        • Frank C.M.
        Second nonocular tumors in survivors of bilateral retinoblastoma: a possible age effect on radiation-related risk.
        Ophthalmology. 1998; 105: 573-580
        • Smith M.A.
        • McCaffrey R.P.
        • Karp J.E.
        The secondary leukemias: challenges and research directions.
        J Natl Cancer Inst. 1996; 88: 407-418
        • Steliarova-Foucher E.
        • Stiller C.
        • Kaatsch P.
        • et al.
        Geographical patterns and time trends of cancer incidence and survival among children and adolescents in Europe since the 1970s (the ACCIS project): an epidemiological study.
        Lancet. 2004; 364: 2097-2105
        • Kramárová E.
        • Stiller C.A.
        The international classification of childhood cancer.
        Int J Cancer. 1996; 68: 759-765
        • Berkson J.
        • Gage R.P.
        Calculation of survival rates for cancer.
        Mayo Clin Proc. 1950; 25: 270-286
        • Kalbfleisch J.D.
        • Prentice R.L.
        The statistical analysis of failure time data.
        John Wiley & Sons, New York1980
        • Peto R.
        • Pike M.C.
        • Armitage P.
        • et al.
        Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples.
        Br J Cancer. 1977; 35: 1-39
        • Moll A.C.
        • Imhof S.M.
        • Bouter L.M.
        • et al.
        Second primary tumors in patients with hereditary retinoblastoma: a register-based follow-up study, 1945–1994.
        Int J Cancer. 1996; 67: 515-519
        • Fletcher O.
        • Easton D.
        • Anderson K.
        • Gilham C.
        • Jay M.
        • Peto J.
        Lifetime risks of common cancers among retinoblastoma survivors.
        J Natl Cancer Inst. 2004; 96: 357-363
        • Kleinerman R.A.
        • Tucker M.A.
        • Tarone R.E.
        • et al.
        Risk of new cancers after radiotherapy in long-term survivors of retinoblastoma: an extended follow-up.
        J Clin Oncol. 2005; 23: 2272-2279